scutellarin has been researched along with Stomach Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meng, M; Sun, J | 1 |
| Chen, L; Chen, W; Guo, X; Liu, D; Liu, X; Liu, Z; Wang, Z; Wei, Z | 1 |
| Li, F; Niu, M; Wang, S | 1 |
3 other study(ies) available for scutellarin and Stomach Neoplasms
| Article | Year |
|---|---|
Chemoprotective Effect of Scutellarin against Gastric Cancer in Rats: An in vitro and in vivo Study.
Topics: Animals; Antioxidants; Apigenin; Body Weight; Carcinogenesis; Cytokines; Glucuronates; Methylnitronitrosoguanidine; Rats; Stomach Neoplasms | 2022 |
Scutellarin Suppressed Proliferation and Induced Apoptosis in Gastric Cancer via Wnt/β-catenin Signaling Pathway.
Topics: Apoptosis; beta Catenin; Cell Line, Tumor; Cell Proliferation; Humans; Stomach Neoplasms; Wnt Signaling Pathway | 2023 |
Scutellarin Inhibits the Growth and EMT of Gastric Cancer Cells through Regulating PTEN/PI3K Pathway.
Topics: Animals; Antineoplastic Agents; Apigenin; Apoptosis; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Glucuronates; Humans; Mice, Nude; Phosphatidylinositol 3-Kinase; PTEN Phosphohydrolase; Signal Transduction; Stomach Neoplasms | 2021 |